New drug designed to prevent chronic migraines

The U-S Food and Drug Administration has approved a new drug said to be the first designed to prevent chronic migraines.

Aimovig is a monthly shot developed by American drug maker Amgen and drug giant Novartis AG, and will cost almost seven-thousand dollars a year without insurance.

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don’t help much or cause serious side effects.

Posted in News & Sports

+ Follow Us

 

Upcoming Events

  1. 12th Annual Giant Book Sale

    October 19 @ 1:00 pm - October 21 @ 4:00 pm
  2. Multi-Vendor Expo

    October 20 @ 10:00 am - 3:00 pm
  3. Hill Brothers Bluegrass Band

    October 20 @ 5:00 pm - 8:00 pm
  4. Wild West Cabaret and Chili Chow-Down

    October 20 @ 5:00 pm
  5. Hamilton Beer Tour

    October 21 @ 9:30 am - 5:00 pm

+ On-Air & Shows